Skip to content

A comparative research for clinical and pathological features about bladder neoplasms with diabetes mellitus

A comparative research for clinical and pathological features about bladder neoplasms with diabetes mellitus

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900027660
Enrollment
Unknown
Registered
2019-11-23
Start date
2019-11-30
Completion date
Unknown
Last updated
2019-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bladder neoplasms and diabetes mellitus

Interventions

Case series:diabetes mellitus

Sponsors

First Affiliated Hospital of the Air Force Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. the patients were treated with cystoscopic tumor resection, partial cystectomy or total cystectomy in our hospital, and the complete tumor tissue was removed, and the diagnosis of bladder tumor was confirmed by pathology; 2. the patients should be operated in our hospital for the first time and diagnosed with bladder tumor.

Exclusion criteria

Exclusion criteria: 1. secondary or metastatic bladder cancer, such as primary cancer in respiratory system, digestive system and other cancers transferred to the bladder; 2. bladder cancer diagnosed outside the study period, with other cancer history; 3. bladder cancer patients who have been treated before, such as radiotherapy and chemotherapy, hand resection, etc.; 4. bladder cancer patients who have not been operated for the first time; 5. electronic medical record information is not available Completeness.

Design outcomes

Primary

MeasureTime frame
Pathological characteristics;

Countries

China

Contacts

Public ContactZHANG Hua

First Affiliated Hospital of the Air Force Military Medical University

popp_1234@163.com+86 13991143132

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026